My personal mission is to create and grow companies with technologies capable of enabling state changes in life sciences where a primary barrier is deployment and commercialization.
I have been the sales & marketing executive in the creation of several emerging companies & markets: computational chemistry (Biovia/Dassault), gene expression analytics (OmniViz, now Instem), RFID labeling for medical devices (Wavemark acquired by Cardinal Health), adaptive clinical trial designs (Cytel/New Mountain).
I am interested in building companies not simply excellent and leading edge but also companies exciting and fun to work for and do business with.
I specialize in innovation in practice, deploying resources better and maximizing the probability of success. Everyone says this … few deliver.